In the UK, bladder cancer is the 7th most common cancer and has a high recurrence rate, affecting 28 people daily. Early detection is crucial, as 5-year survival rates can be as high as 80% if treated early.
A new study published in the Journal of Urology reports that prostate cancer patients treated with androgen deprivation therapy (ADT) experienced changes in mental and emotional well-being during treatment, with no significant decline in emotional quality of life two years after treatment. Investigators recommend counseling men about p...
Researchers successfully transplanted kidneys into 50 recipients using a robot-assisted procedure that cools the organ with sterile ice during operation. This innovative method reduces post-operative pain and complications compared to traditional open surgery.
Patients with pre-existing chronic kidney disease who underwent robot-assisted partial nephrectomy for kidney cancer experienced minimal loss of kidney function compared to those with normal kidney function. The procedure also showed no cases of end-stage kidney disease requiring long-term dialysis.
Researchers at Children's Hospital of Orange County (CHOC) have identified a new technique that reduces postoperative pain in children following high-risk urology surgeries, resulting in less need for pain medicine. The study evaluates continuous infusion of local anesthesia using the ON-Q pain relief system and shows promising results.
Elsevier's new open access journal Urology Case Reports provides a platform for urologists to publish short, well-illustrated case reports. The first case report, describing a rare neoplasm of the urinary bladder, is now available online.
A study by researchers at Henry Ford Hospital found that while minimally invasive nephrectomy is gaining popularity, it still accounts for less than 10% of pediatric kidney surgeries. The majority of procedures are performed on children under age one and those with benign conditions.
Researchers at Henry Ford's Vattikuti Urology Institute found instances of ureteral injury in 6,442 patients who underwent robotic prostatectomy. Patient characteristics such as infection history, abdominal surgery, and enlarged prostate glands may forewarn such damage.
A new study found that supervised exercise sessions improve cardiopulmonary fitness in an elderly population awaiting radical cystectomy, a common treatment for muscle-invasive bladder cancer. The results suggest that preoperative exercise training may reduce postoperative complications and hospital stays.
A Polish study has developed a new imaging modality using Magnetic Resonance Imaging-Ultrasound (MRIUS) to guide prostate biopsies, yielding higher sensitivity rates compared to traditional TRUS biopsies. The technology, which fuses MRI with TRUS images, allows for real-time guidance of targeted biopsies in office settings.
A new study conducted by Portuguese urologists found enterocystoplasty to be a safe and effective surgical option for children with developmental abnormalities of the genitourinary system. The procedure showed low rates of severe complications, including successful bladder function improvement in 24 patients.
A recent study found that detecting changes in circulating tumor cells (CTC) may be more accurate than tracking prostate-specific antigen (PSA) levels to predict treatment outcomes in patients with castration-resistant prostate cancer. The study showed a favorable change in CTC detection occurred in over half of patients during chemoth...
A study by Henry Ford Hospital urologists found that while women are more prone to urinary tract infections, men are more likely to be hospitalized for treatment. The researchers discovered that older men and those with serious kidney infections were most often admitted to the hospital.
The Latin American Urology Association names its highest accolade after UCLA's Dr. Shlomo Raz in recognition of his efforts to educate and train urologists in the region. The inaugural Shlomo Raz Medal will be awarded annually to a deserving urologist who furthered Raz's mission.
The ASTRO/AUA joint guideline offers clinical principles and recommendations for radiation therapy use in patients with and without evidence of prostate cancer recurrence. The guideline is based on a comprehensive review of 324 research articles and provides detailed efficacy data for patients with detectable and undetectable PSA levels.
A new study by Dr. Peter Kronenberg and Prof. Olivier Traxer found significant discrepancies between advertised and measured laser fiber diameters, with some fibers being up to double the thickness promoted. The study's findings highlight the importance of accurate technical specifications in urology surgery.
A new three-gene biomarker can accurately predict which low-risk prostate cancers will become aggressive, helping doctors determine whether men need active surveillance or invasive treatment. The test has shown promising results in a retrospective study of 43 patients, and further clinical trials are planned.
The Journal of Spinal Cord Medicine has published a new issue focusing on the latest research and treatment developments in spinal cord injury. The issue includes articles on various topics such as botulinum toxin use, urology, neuroscience, rehabilitation psychology, and more.
Researchers at Henry Ford Hospital developed a new technique using ice slush and robotic surgery to remove large kidney stones. The ICE procedure provides kidney protection during blood flow stoppage, allowing for complex surgeries. Three patients were successfully treated without complications.
The study found a significant increase in women's risk of developing kidney stones, with more cases being seen in emergency departments over a four-year period. The rate of hospitalization remained stable, but the use of CT scans to diagnose kidney stones may contribute to the rise in emergency department charges.
Stem cells found in urine have been shown to differentiate into various cell types, including bladder, bone, cartilage, and endothelial cells. These cells offer a promising alternative for autologous therapy, potentially treating urology-related conditions and other fields.
A recent URMC study questions the assumption that saving kidney tissue during surgery improves patient outcomes and survival rates, suggesting radical nephrectomy may be a viable option for certain patients with small kidney cancers.
A Swedish data-sharing campaign led to a significant decrease in unnecessary medical tests for low-risk prostate cancer patients. The study suggests that curtailing unneeded medical tests is achievable and offers insights into the importance of implementing guidelines and providing feedback to practitioners.
A Stanford-led study found that men diagnosed with azoospermia have a significantly higher risk of developing cancer than the general population. The study, which analyzed data from over 2,200 infertile men, found that azoospermic men were nearly three times more likely to receive a cancer diagnosis than non-azoospermic men.
A three-year study published in The Journal of Urology finds that tibial nerve stimulation significantly improves symptoms of overactive bladder. Participants experienced a nearly 30% decrease in daytime trips to the bathroom and almost 40% fewer nighttime trips.
A study found that robot-assisted partial nephrectomy is a safe operation with superior results compared to open and laparoscopic surgery. However, it also involves more excessive hospital charges, despite no cost-savings.
The new guideline provides detailed direction on treatment options for prostate cancer patients, including adjuvant and salvage radiotherapy recommendations. It emphasizes the importance of informed consent and patient education on potential side effects and benefits of radiation therapy.
A recent study found that women are more likely to undergo percutaneous nephrolithotomy (PCNL), a minimally invasive procedure to remove medium to large kidney stones. The study also discovered an increase in blood infection and overall complications, with sepsis incidence doubling from 1.2% to 2.4%.
Researchers at UT Southwestern Medical Center found that a marker panel can predict which patients are more likely to experience cancer recurrence after bladder removal. The study identifies patients who could benefit from follow-up chemotherapy to improve treatment outcomes.
A study by Henry Ford Health found that ER visits for urinary tract infections result in nearly $4 billion in unnecessary costs each year. The research analyzed data from 10.8 million patients with a primary diagnosis of UTI who visited emergency rooms from 2006 to 2009.
The data presented at the AUA Annual Meeting shows that degarelix lowers the risk of cardiovascular events or death when compared to luteinising hormone-releasing agonists. Analysis of disease control-related outcomes from six comparative randomised clinical trials also supports this finding.
Researchers at UCLA have classified kidney cancer into several unique subtypes, which will aid in tailoring treatment to individual patients. The study, conducted over 10 years, identified deletions of chromosomes 3p and 14q in clear cell renal carcinoma tumors, associated with improved survival rates for some patients.
A new study reveals that correcting PSA levels for genetic variants can significantly reduce unnecessary biopsies and false complacency. By tailoring screening levels to an individual's genetic makeup, the risk of prostate cancer can be more accurately assessed. This approach has the potential to prevent up to 15% to 20% of biopsies.
A recent study by Henry Ford Hospital reveals that the rise in minimally invasive kidney stone surgery has led to a higher incidence of blood infections and overall complications among female patients. The procedure's use has increased by 47% since 1999, with women making up a larger share of those undergoing the treatment.
A retrospective multicenter study of 677 patients found that intraoperative, early postoperative, and mesh-related complications are common in pelvic organ prolapse surgery. Mesh-related complications were the most common, with erosion being the most frequent complication.
A new study analyzed 6.2 million patients and found that 74.6% of men with erectile dysfunction remained untreated, highlighting the need for improved treatment access and awareness. The study also showed that treatment frequency varied by co-morbidities, with hypogonadism being a key factor in treatment usage.
A recent study by the European Association of Urology has shown promising results for a combined vaccine and steroid drug therapy in treating chemotherapy-naive castration-resistant prostate cancer (CRPC). The therapy, which involves multi-peptide vaccination therapy with low-dose dexamethasone, has been shown to significantly improve ...
A Dutch study found that abiraterone can block androgen receptor activation directly, in addition to inhibiting CYP17A1 activity. This suggests a new mechanism of action for treating castration-resistant prostate cancer.
Researchers found that nano-hMSCs can promote cavernous neuronal regeneration and repair erectile dysfunction. The study revealed that transplantation of nano-hMSCs increased the expression levels of cavernous neuronal, endothelial, and smooth muscle makers.
A genetic score based on PCa risk-associated SNPs improves predictive performance of existing clinical variables, especially for patients with low PSA levels. The study identified 25 SNPs significantly associated with PCa risk and found that the genetic score was an independent predictor of biopsy outcomes.
A study published in the Journal of Urology analyzed 25 years of data after radiation therapy for prostate cancer patients and found that follow-up evaluations are necessary for 15 years after treatment. The study also confirmed using radiation therapy results in comparable disease-free survival rates to radical prostatectomy.
The EAU has made its patient information available in Spanish and Greek to cater to patients from diverse linguistic backgrounds. This move aims to provide trustworthy information on urological diseases to all European patients, with translations coordinated by national societies.
A natural product called genistein-combined polysaccharide (GCP) may help patients with metastatic prostate cancer live longer by blocking a key mechanism used by prostate cancer cells to survive. GCP is expected to be effective in treating patients with low response to androgen-deprivation therapy.
The European Association of Urology (EAU) is releasing a policy statement on live surgery ethics, prioritizing patient safety. The statement aims to establish uniform standards and monitor outcomes for EAU-approved live surgery events.
A study of 17 clinical trials found that 70% of men taking Cialis for 12 weeks could ejaculate most of the time and reach orgasm, compared to 30% in the placebo group. The benefits were seen across all levels of ED severity.
A two-year observational follow-up of the REDUCE trial found that dutasteride treatment was associated with a lower incidence of new prostate cancers. The study, published in The Journal of Urology, showed that men taking dutasteride had fewer prostate cancer diagnoses compared to those receiving a placebo.
A Kaiser Permanente study found that annual percent changes in prostate-specific antigen (PSA) levels are more accurate for detecting aggressive prostate cancer than single measurements. The study analyzed nearly 220,000 men and found a moderate increase in PSA levels with age.
Researchers found that microscopic hematuria does not necessarily indicate cancer, and patients with this condition may avoid unnecessary tests. A new model, the Hematuria Risk Index, predicts renal and bladder cancer risk, reducing unnecessary work-ups.
A comprehensive study analyzed 232 papers on prostate cancer treatments and found that surgery is the most cost-effective option, saving lives at a lower cost than radiation therapy. The analysis also showed that treatment plans for localized prostate cancer vary dramatically across different centers.
A Loyola University Medical Center study found that physician review websites are based on scores from an average of only 2.4 patients, highlighting the need for more reviews to make them reliable.
A study by Dana-Farber Cancer Institute found that a small percentage of men treated for prostate cancer reported a perceived shortening of their penis, leading to regrets about treatment choice. The complaint was more common in men treated with radical prostatectomy or male hormone-blocking drugs combined with radiation therapy.
Thomas Jefferson University researchers have identified new pathways that drive aggressive forms of prostate cancer. Elevated levels of Cyclin D1b function as a novel biomarker for lethal metastatic disease in prostate cancer patients.
A new study published in the Journal of Urology found that robotic-assisted laparoscopic radical cystectomy (RARC) resulted in decreased estimated blood loss and shorter hospital stays compared to open radical cystectomy (ORC) for patients with muscle-invasive bladder cancer. RARC also showed a trend towards faster return of bowel func...
Researchers at Henry Ford Hospital have developed a new technique for minimally invasive robotic partial nephrectomy procedures, sparing the kidney and eliminating long hospital stays. The technique, called ICE, provides better outcomes by giving surgeons more time to perform the procedure and allows for better tumor removal and analysis.
A new targeted prostate biopsy technique using magnetic resonance ultrasound fusion has been shown to improve diagnosis of prostate cancer and aid in selecting patients for active surveillance. The study found that the biopsies identified 90 out of 171 men with prostate cancer, highlighting its potential as a more accurate and efficien...
A new imaging-guided targeted biopsy method using MRI and ultrasound fusion has been shown to detect prostate cancer more accurately than traditional blind biopsies. The technique led to a high rate of cancer detection and identification of aggressive tumors, improving patient outcomes.
The study, led by Peter Jones, identified specific genes that must be turned off for cancer cells to survive. The findings provide a new target for cancer treatments and may lead to more effective medicine.
A new drug demonstrated dramatic effects on prostate cancer that had spread to the bone, with two-thirds of patients showing improvements on their bone scans. Additionally, 67% of patients with bone pain reported improved pain control after treatment with cabozantinib.
Stanford researchers use a new animal model to study the early course of urogenital schistosomiasis, a chronic disease affecting 112 million people worldwide. They found that continuous waves of egg deposition are what's generating chronic disease, and that killing the worms can halt the cycle.
Researchers have identified a key pathway called the Unfolded Protein Response (UPR) that helps tumor cells escape programmed cell death during lymphoma development. Inhibiting this pathway could lead to new blood cancer treatments.